📖
Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.
Kusama H, Horimoto Y, Iwai K, Kitaoku Y, Takeda F, Hamaoka R, Iwai M, Mizuuchi M, Ushio T, Orimoto K, Ishikawa T

Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Breast Cancer.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.
Author / Organization Kusama H, Horimoto Y, Iwai K, Kitaoku Y, Takeda F, Hamaoka R, Iwai M, Mizuuchi M, Ushio T, Orimoto K, Ishikawa T
Subject & Discipline Breast Cancer
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-6267
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »